Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,390 | -6,850 | -20,940 | -14,780 | -9,520 |
| Depreciation Amortization | 590 | 720 | 3,340 | 2,590 | 1,780 |
| Other Working Capital | -200 | -200 | 710 | 810 | 360 |
| Other Operating Activity | 940 | 410 | 1,800 | 1,820 | 1,210 |
| Operating Cash Flow | $-12,060 | $-5,920 | $-15,090 | $-9,560 | $-6,170 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -30 | -70 | 0 | 0 |
| Other Investing Activity | -930 | 0 | -580 | -610 | 0 |
| Investing Cash Flow | $-960 | $-30 | $-650 | $-610 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -900 | -470 | 58,490 | 58,950 | 59,360 |
| Financing Cash Flow | $-900 | $-470 | $58,490 | $58,950 | $59,360 |
| Beginning Cash Position | 62,240 | 62,240 | 19,490 | 19,490 | 19,490 |
| End Cash Position | 48,300 | 55,810 | 62,240 | 68,280 | 72,680 |
| Net Cash Flow | $-13,940 | $-6,420 | $42,740 | $48,780 | $53,180 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,060 | -5,920 | -15,090 | -9,560 | -6,170 |
| Free Cash Flow | -12,060 | -5,920 | -15,090 | -9,560 | -6,170 |